EP Patent

EP4146207A1 — Dosage regimen of amlodipine

Assigned to Closed Loop Medicine Ltd · Expires 2023-03-15 · 3y expired

What this patent protects

This invention relates to a dosage regimen for amlodipine for use in the treatment of hypertension.

USPTO Abstract

This invention relates to a dosage regimen for amlodipine for use in the treatment of hypertension.

Drugs covered by this patent

Patent Metadata

Patent number
EP4146207A1
Jurisdiction
EP
Classification
—
Expires
2023-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Closed Loop Medicine Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.